Cargando…

The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality

Background Acute heart failure (AHF) can be life-threatening if not treated promptly and can significantly increase the number of annual emergency department (ED) encounters in the United States. Achieving adequate and prompt euvolemic state in AHF patients using intravenous (IV) diuretics is the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Arshad Muhammad, Mohammed, Sohaib K, Zubair, Nida, Mubarik, Ateeq, Ahmed, Adnan, Jamal, Syed Farrukh, Hassan, Syed Moin, Haq, Furqan, Muddassir, Salman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884126/
https://www.ncbi.nlm.nih.gov/pubmed/33643721
http://dx.doi.org/10.7759/cureus.12742
_version_ 1783651346180734976
author Iqbal, Arshad Muhammad
Mohammed, Sohaib K
Zubair, Nida
Mubarik, Ateeq
Ahmed, Adnan
Jamal, Syed Farrukh
Hassan, Syed Moin
Haq, Furqan
Muddassir, Salman
author_facet Iqbal, Arshad Muhammad
Mohammed, Sohaib K
Zubair, Nida
Mubarik, Ateeq
Ahmed, Adnan
Jamal, Syed Farrukh
Hassan, Syed Moin
Haq, Furqan
Muddassir, Salman
author_sort Iqbal, Arshad Muhammad
collection PubMed
description Background Acute heart failure (AHF) can be life-threatening if not treated promptly and can significantly increase the number of annual emergency department (ED) encounters in the United States. Achieving adequate and prompt euvolemic state in AHF patients using intravenous (IV) diuretics is the cornerstone of treatment, which not only reduces in-hospital stay and mortality but also decreases healthcare expenditures. Surprisingly, the door to diuretic (D2D) time in AHF patients has always been a debatable issue among physicians worldwide, and so far, there are no set guidelines. This study examines a large cohort of AHF patients to determine the association between diuretics use within 90 minutes of ED admission and hospital length of stay (LOS) and patient mortality.  Methods Retrospective institutional data of AHF patients receiving IV diuretics following ED admission were extracted from 2016 to 2017. A total of 7,751 patients treated for AHF exacerbation were included, which were further divided into two groups based on the timing of diuretics administration (<90 minutes vs. ≥90 minutes). The primary outcomes were LOS between the two groups and hospital mortality. The standard statistical methodology was used for data analysis. Results  A total of 7,751 AHF cases receiving IV diuretics were identified. Almost 1,432 patients (18.5%) received IV diuretics within 90 minutes of ER admission (group 1) while 6,319 patients (81.5%) patients received IV diuretics after 90 minutes (group 2). Furthermore, among group 1 patients, average LOS was noted to be associated with shorter hospitalization (average of 1.423 days less as compared to group 2 patients (confidence interval (CI) =1.02-1.82; p<0.05). Finally, after controlling for other mortality risk factors, patients in group 2 were 1.435 times more likely to have died compared to patients in group 1 (CI=1.03-1.98; p<0.05). Conclusions  D2D time in AHF patients has always been a crucial judgmental decision. The current study successfully demonstrated the relation between IV diuretics administration within 90 minutes of ED admission, favorable clinical outcomes, and decreased mortality rates. More adequately powered studies are needed to validate the results of our current study further.
format Online
Article
Text
id pubmed-7884126
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-78841262021-02-27 The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality Iqbal, Arshad Muhammad Mohammed, Sohaib K Zubair, Nida Mubarik, Ateeq Ahmed, Adnan Jamal, Syed Farrukh Hassan, Syed Moin Haq, Furqan Muddassir, Salman Cureus Cardiology Background Acute heart failure (AHF) can be life-threatening if not treated promptly and can significantly increase the number of annual emergency department (ED) encounters in the United States. Achieving adequate and prompt euvolemic state in AHF patients using intravenous (IV) diuretics is the cornerstone of treatment, which not only reduces in-hospital stay and mortality but also decreases healthcare expenditures. Surprisingly, the door to diuretic (D2D) time in AHF patients has always been a debatable issue among physicians worldwide, and so far, there are no set guidelines. This study examines a large cohort of AHF patients to determine the association between diuretics use within 90 minutes of ED admission and hospital length of stay (LOS) and patient mortality.  Methods Retrospective institutional data of AHF patients receiving IV diuretics following ED admission were extracted from 2016 to 2017. A total of 7,751 patients treated for AHF exacerbation were included, which were further divided into two groups based on the timing of diuretics administration (<90 minutes vs. ≥90 minutes). The primary outcomes were LOS between the two groups and hospital mortality. The standard statistical methodology was used for data analysis. Results  A total of 7,751 AHF cases receiving IV diuretics were identified. Almost 1,432 patients (18.5%) received IV diuretics within 90 minutes of ER admission (group 1) while 6,319 patients (81.5%) patients received IV diuretics after 90 minutes (group 2). Furthermore, among group 1 patients, average LOS was noted to be associated with shorter hospitalization (average of 1.423 days less as compared to group 2 patients (confidence interval (CI) =1.02-1.82; p<0.05). Finally, after controlling for other mortality risk factors, patients in group 2 were 1.435 times more likely to have died compared to patients in group 1 (CI=1.03-1.98; p<0.05). Conclusions  D2D time in AHF patients has always been a crucial judgmental decision. The current study successfully demonstrated the relation between IV diuretics administration within 90 minutes of ED admission, favorable clinical outcomes, and decreased mortality rates. More adequately powered studies are needed to validate the results of our current study further. Cureus 2021-01-16 /pmc/articles/PMC7884126/ /pubmed/33643721 http://dx.doi.org/10.7759/cureus.12742 Text en Copyright © 2021, Iqbal et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Iqbal, Arshad Muhammad
Mohammed, Sohaib K
Zubair, Nida
Mubarik, Ateeq
Ahmed, Adnan
Jamal, Syed Farrukh
Hassan, Syed Moin
Haq, Furqan
Muddassir, Salman
The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality
title The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality
title_full The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality
title_fullStr The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality
title_full_unstemmed The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality
title_short The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality
title_sort impact of door to diuretic time in acute heart failure on hospital length of stay and in-patient mortality
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884126/
https://www.ncbi.nlm.nih.gov/pubmed/33643721
http://dx.doi.org/10.7759/cureus.12742
work_keys_str_mv AT iqbalarshadmuhammad theimpactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT mohammedsohaibk theimpactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT zubairnida theimpactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT mubarikateeq theimpactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT ahmedadnan theimpactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT jamalsyedfarrukh theimpactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT hassansyedmoin theimpactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT haqfurqan theimpactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT muddassirsalman theimpactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT iqbalarshadmuhammad impactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT mohammedsohaibk impactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT zubairnida impactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT mubarikateeq impactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT ahmedadnan impactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT jamalsyedfarrukh impactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT hassansyedmoin impactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT haqfurqan impactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality
AT muddassirsalman impactofdoortodiuretictimeinacuteheartfailureonhospitallengthofstayandinpatientmortality